Back to Screener

Healthcare

Alterity Therapeutics Limited(ATHE)

Live Price

Offline

$4.82

-1.63% today

1Y Change

+21.27%

Window

Jun 30, 2025 โ†’ Jun 23, 2026

Market Cap
$110.00M
Revenue Growth
+35.3%
EPS Growth
+63.5%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 30, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Alterity Therapeutics Limited (ATHE) is a Healthcare stock with a market cap of $110.00M and listed on NASDAQ. The stock last traded around $4.82 and up 21.3% across the available one-year price window (Jun 30, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +35.3%, EPS growth of +63.5%, a dividend yield of 0.0%. What stands out right now is revenue +35.3%, EPS +63.5%, free cash flow +9.2% with operating margin -525.6% and ROIC -31.3%. Valuation already assumes a fairly strong business story at price/sales 28.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ATHE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

ATHE vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

ATHE is 2.54 pts ahead over the shared 1Y window.

ATHE had 46.29 pts deeper max drawdown than SPY.

ATHE beat SPY in 1 of 2 calendar years shown and trailed in 1.

ATHE

+21.27%

Normalized return

SPY

+18.73%

S&P 500

Excess Return

+2.54 pts

Relative to SPY

ATHE Max Drawdown

-55.42%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

ATHESPY

Calendar-Year Returns

Uses the longest available daily history for ATHE and SPY.

YearATHESPYExcessLeader
2026+56.96%+6.71%+50.26 ptsATHE
2025-25.18%+11.19%-36.38 ptsSPY

Earnings Reports

๐Ÿ“… Next earningsAug 28, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Aug 28, 26
TBD
โ€”
Est -0.04
โ€”
โ€”
Est 1866.9B
โ€”
Aug 28
โ€”
Feb 25, 26
โœ—
-0.38
Est -0.23
-65.9%
645.9B
Est 1069.4B
-39.6%
Feb 25
โ€”
Aug 28, 25
โœ“
-0.40
Est -0.43
+7.2%
3833.0B
Est 5050.8B
-24.1%
Aug 28
โ€”
Aug 4, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Aug 4
โ€”
Feb 28, 25
โœ“
-0.00
Est -0.53
+99.9%
803.0B
Est 2303.3B
-65.1%
Feb 28
โ€”
Feb 3, 25
-0.00
Est โ€”
โ€”
803.0B
Est โ€”
โ€”
Feb 3
โ€”
Aug 29, 24
โœ“
-0.00
Est -0.05
+96.2%
2118.6B
Est 950.0B
+123.0%
Aug 29
โ€”
Apr 11, 24
-0.00
Est โ€”
โ€”
1059.3B
Est โ€”
โ€”
Apr 11
โ€”
Feb 28, 24
โœ“
-0.00
Est -0.11
+97.5%
1900.7B
Est 958.3B
+98.3%
Feb 28
โ€”
Jan 30, 24
-0.00
Est โ€”
โ€”
950.4B
Est โ€”
โ€”
Jan 30
โ€”
Jun 30, 23
-0.00
Est โ€”
โ€”
1530.5B
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 23
โœ“
-0.00
Est -0.12
+99.0%
765.2B
Est 1499.3B
-49.0%
Mar 31
โ€”
Feb 28, 23
โœ“
-1.11
Est -1.81
+38.6%
7.7B
Est 1821.9B
-99.6%
Feb 28
โ€”
Dec 31, 22
-0.00
Est โ€”
โ€”
2385.8B
Est โ€”
โ€”
Dec 31
โ€”
Aug 30, 22
โœ“
-1.43
Est -1.97
+27.5%
1822.5B
Est 2868.5B
-36.5%
Aug 30
โ€”
Jun 30, 22
-0.00
Est โ€”
โ€”
2764.3B
Est โ€”
โ€”
Jun 30
โ€”
Feb 28, 22
-0.98
Est โ€”
โ€”
980M
Est โ€”
โ€”
Feb 28
โ€”
Dec 31, 21
-0.00
Est โ€”
โ€”
2359.2B
Est โ€”
โ€”
Dec 31
โ€”
Aug 31, 21
โ€”
Est -1.43
โ€”
โ€”
Est 1389.8B
โ€”
Aug 31
โ€”
Jun 30, 21
-0.00
Est โ€”
โ€”
2456.3B
Est โ€”
โ€”
Jun 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar